Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.8816
0.00 (0.00%)
May 14, 2025, 4:00 PM - Market open
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $111.21 million as of May 15, 2025. Its market cap has decreased by -64.34% in one year.
Market Cap
111.21M
Enterprise Value
1.74M
1-Year Change
-64.34%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has decreased from $117.04M to $111.21M, a decrease of -4.98%. That is a compound annual growth rate of -1.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 116.94M | -44.56% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 642.38B |
| Johnson & Johnson | 352.15B |
| AbbVie | 313.43B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 279.41B |
| Abbott Laboratories | 223.67B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |